Literature DB >> 22521561

Increase in breast cancer incidence among older women in Mumbai: 30-year trends and predictions to 2025.

Rajesh P Dikshit1, B B Yeole, Rajini Nagrani, P Dhillon, R Badwe, Freddie Bray.   

Abstract

BACKGROUND: Increasing trends in the incidence of breast cancer have been observed in India, including Mumbai. These have likely stemmed from an increasing adoption of lifestyle factors more akin to those commonly observed in westernized countries. Analyses of breast cancer trends and corresponding estimation of the future burden are necessary to better plan rationale cancer control programmes within the country.
METHODS: We used data from the population-based Mumbai Cancer Registry to study time trends in breast cancer incidence rates 1976-2005 and stratified them according to younger (25-49) and older age group (50-74). Age-period-cohort models were fitted and the net drift used as a measure of the estimated annual percentage change (EAPC). Age-period-cohort models and population projections were used to predict the age-adjusted rates and number of breast cancer cases circa 2025.
RESULTS: Breast cancer incidence increased significantly among older women over three decades (EAPC = 1.6%; 95% CI 1.1-2.0), while lesser but significant 1% increase in incidence among younger women was observed (EAPC = 1.0; 95% CI 0.2-1.8). Non-linear period and cohort effects were observed; a trends-based model predicted a close-to-doubling of incident cases by 2025 from 1300 mean cases per annum in 2001-2005 to over 2500 cases in 2021-2025.
CONCLUSIONS: The incidence of breast cancer has increased in Mumbai during last two to three decades, with increases greater among older women. The number of breast cancer cases is predicted to double to over 2500 cases, the vast majority affecting older women.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22521561     DOI: 10.1016/j.canep.2012.03.009

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  7 in total

1.  Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer.

Authors:  Sachin S Hingmire; Mahesh B Sambhus; Dhananjay S Kelkar; Sujit Joshi; Purvish M Parikh; R Bharath
Journal:  South Asian J Cancer       Date:  2017 Apr-Jun

2.  The proportion of cancer-related entries in PubMed has increased considerably; is cancer truly "The Emperor of All Maladies"?

Authors:  Constantino Carlos Reyes-Aldasoro
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

3.  Global Burden of Female Breast Cancer: Age-Period-Cohort Analysis of Incidence Trends From 1990 to 2019 and Forecasts for 2035.

Authors:  Yizhen Li; Jinxin Zheng; Yujiao Deng; Xinyue Deng; Weiyang Lou; Bajin Wei; Dong Xiang; Jingjing Hu; Yi Zheng; Peng Xu; Jia Yao; Zhen Zhai; Linghui Zhou; Si Yang; Ying Wu; Huafeng Kang; Zhijun Dai
Journal:  Front Oncol       Date:  2022-06-09       Impact factor: 5.738

4.  Breast reconstruction awareness among educated women in a metropolitan city.

Authors:  Deepak S Kothari; Amol N Ghalme; Sagar R Gundewar
Journal:  Indian J Plast Surg       Date:  2012-09

5.  Addressing the younger age at onset in breast cancer patients in Asia: an age-period-cohort analysis of fifty years of quality data from the international agency for research on cancer.

Authors:  Seyed Houssein Mousavi-Jarrrahi; Amir Kasaeian; Kamyar Mansori; Mehdi Ranjbaran; Mahmoud Khodadost; Alireza Mosavi-Jarrahi
Journal:  ISRN Oncol       Date:  2013-09-02

6.  Trends in mouth cancer incidence in Mumbai, India (1995-2009): An age-period-cohort analysis.

Authors:  Krithiga Shridhar; Preetha Rajaraman; Shravani Koyande; Purvish M Parikh; Pankaj Chaturvedi; Preet K Dhillon; Rajesh P Dikshit
Journal:  Cancer Epidemiol       Date:  2016-04-01       Impact factor: 2.984

7.  Central obesity increases risk of breast cancer irrespective of menopausal and hormonal receptor status in women of South Asian Ethnicity.

Authors:  R Nagrani; S Mhatre; P Rajaraman; I Soerjomataram; P Boffetta; S Gupta; V Parmar; R Badwe; R Dikshit
Journal:  Eur J Cancer       Date:  2016-08-27       Impact factor: 9.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.